ImmuneOncia aims to develop immuno-oncology therapeutics

to transform the standard of care in cancer treatment

  • About Us
  • Leadership

Leadership

ImmuneOncia will lead the global biopharmaceutical industry through the development of innovative immuno-oncology therapeutics
Heung Tae Kim

CEO & CMO
  • Head Center for Clinical Trials, Lung Cancer, Director Office of Planning & Coordination National Cancer Center(NCC)
  • Director, National Cancer Control Planning Board, Ministry of Health & Welfare
  • Chair of General Assembly, Korean society of medical oncology(KSMO)
  • Visiting Fellow, National Cancer Institute(NCI/NIH)
  • Ph.D in Medicine, SNU, Seoul, Korea
  • Sung Ho Kim CTO, Division Head of R&BD
    • Team Leader, Korea Drug Development Fund(KDDF)
    • CTO, KOBIOLABS
    • Chief Researcher, YUHAN
    • Team Leader, ProCell Therapeutics
    • Ph.D in Life Sciences, SNU, Seoul, Korea
  • Dong Hyun Yoon CFO, Division Head of Business Planning
    • CFO in Theragen Bio
    • CFO in GreenCross MS (GC MS)
    • Finance Director, Thermo Fisher Scientific Korea
    • BS in Accounting, Chung-Ang Univ. Seoul, Korea
  • Sung Young Lee Division Head of Clinical Strategy & Operation
    • Department Leader of Clinical Planning, Celltrion
    • PM, Team Leader, National Cancer Center(NCC)
    • Ph.D. course completion in Nursing, SNU, Seoul, Korea
  • Seyoon Kim Dept. Leader Business Development
    • Team Leader, Biopharm Group, Samyang Holdings
    • Team Leader, Samyang Biopharm
    • Senior Manager, Samyang USA
    • Ph.D in Chemistry, Yonsei Univ. Seoul, Korea
  • Yang Kyun Ryu Dept. Leader CMC
    • Team Leader, Korea Drug Development Fund(KDDF)
    • Principal Scientist, Samsung BioEpis
    • Senior Manager, SK Chemicals
    • Ph.D. in Life Sciences, SNU, Seoul, Korea
  • Scientific Advisory Board(SAB)
    • Prof. Junho Chung (College of Medicine, Seoul National University)
    • Prof. Sang Taek Jung (Dept. Chemical and Biological Engineering, SNU)
  • Clinical Advisory Board(CAB)
    • Prof. Won Seog Kim (Div. of Hematology-Oncology, Samsung Medical Center)
    • Prof. Jin Seok Ahn (Div. of Hematology-Oncology, Samsung Medical Center)
    • Prof. Kyung Hae Jung (Univ. of Ulsan College of Medicine, Asan Medical Center)
    • Prof. Keun-Wook Lee (College of Medicine, Seoul National University)
    • Prof. Min Kyu Jung (College of Medicine, Yonsei University)
    • Prof. Chul Woo Ahn (UT Southwestern Medical Center)
    • Prof. Hwi-yeol Yun (College of Pharmacy, Chungnam National University)